@BusinessDaily

UK multinational to sell new cancer medicines in Kenya

9 months ago, 3 Jan 18:02

By: James Kariuki

UK-based drugmaker, Clinigen, has announced plans to introduce its three cancer drugs in the Kenyan market.  In a statement, Clinigen Group Plc said it had granted Eisai Europe exclusive rights to seek licences from Kenyan authorities for the three brands, Halaven (eribulin), Fycompa (perampanel) and Lenvima (lenvatinib). Clinigen’s South Africa managing director Benjamin Miny said: “We are able to leverage our extensive distribution network in the region and local expertise to enable access to these important medicines, helping to address the unmet medical needs of patients and their families across southern Africa.” The agreement will also see Eisai seek regulatory approval for the three drugs in Namibia, Botswana, Zimbabwe, Zambia, Ghana, Nigeria, Uganda and Tanzania. It has since obtained approvals to sell Halaven and Fycompa in South Africa. Halaven is currently licensed in South Africa only for the treatment of women with locally advanced or metastatic breast cancer after having undergone at least two chemotherapeutic regimens for the ailment. Fycompa, also licensed in South Africa, is used for stabilising patients suffering from partial-onset seizures, with or without secondarily generalised seizures in patients with epilepsy aged 12 and above. Lenyima is used for treating adult patients suffering from various types of thyroid cancer. According to available statistics, the number of people dying from cancer has been increasing, mainly blamed on sedentary lifestyles and poor diet.
Read More


Category: business news corporate economy opinion markets lifestyle

Suggested

4 hours ago, 00:17
@StandardMedia - By: Macharia Kamau
Telcos lose control of agents as unregistered SIM cards rocket

Rush for sales sidesteps regulations on customer identification and exposes subscribers to fraud. ...

Category: topnews news business
4 hours ago, 00:17
@StandardMedia - By: Moses Omusolo
Vivo wraps up Engen deal for Sh20 billion

Pact will see firm take over rival’s outlets in eight countries, including Kenya. ...

Category: business news
11 hours ago, 17:19
@DailyNation - By: Lynet Igadwah
Mobile firms given 2 days to switch off illegal subscribers

Mobile operators have until Friday to remove unregistered subscribers and those listed using fraudulent documents from their networks or face fines of up to 0.2 per cent of their annual sales. ...

Category: topnews news business
11 hours ago, 17:08
@BusinessDaily - By: Jenny Lues
It’s time to rethink our expenditure plans

Kenya finds itself at a crossroads. It needs a better future, in terms of health and education, and lives lived. But in our modern world that depends on money, and money is made by business. ...

Category: business news markets economy lifestyle opinion
17 hours ago, 11:37
@DailyNation - By: Constant Munda
Treasury sees growth hitting seven-year high

The imposition VAT on fuel has triggered widespread fears that the economy is bound to deeply suffer. ...

Category: topnews news business
11 hours ago, 17:19
@BusinessDaily - By: Nasibo Kabale
Medics in strike threat over Pumwani saga

Doctors have threatened to go on a countrywide strike if the suspended colleagues from Pumwani hospital are not reinstated. ...

Category: business economy news corporate

@BusinessDaily

UK multinational to sell new cancer medicines in Kenya

9 months ago, 3 Jan 18:02

By: James Kariuki
UK-based drugmaker, Clinigen, has announced plans to introduce its three cancer drugs in the Kenyan market.  In a statement, Clinigen Group Plc said it had granted Eisai Europe exclusive rights to seek licences from Kenyan authorities for the three brands, Halaven (eribulin), Fycompa (perampanel) and Lenvima (lenvatinib). Clinigen’s South Africa managing director Benjamin Miny said: “We are able to leverage our extensive distribution network in the region and local expertise to enable access to these important medicines, helping to address the unmet medical needs of patients and their families across southern Africa.” The agreement will also see Eisai seek regulatory approval for the three drugs in Namibia, Botswana, Zimbabwe, Zambia, Ghana, Nigeria, Uganda and Tanzania. It has since obtained approvals to sell Halaven and Fycompa in South Africa. Halaven is currently licensed in South Africa only for the treatment of women with locally advanced or metastatic breast cancer after having undergone at least two chemotherapeutic regimens for the ailment. Fycompa, also licensed in South Africa, is used for stabilising patients suffering from partial-onset seizures, with or without secondarily generalised seizures in patients with epilepsy aged 12 and above. Lenyima is used for treating adult patients suffering from various types of thyroid cancer. According to available statistics, the number of people dying from cancer has been increasing, mainly blamed on sedentary lifestyles and poor diet.
Read More

Category: business news corporate economy opinion markets lifestyle

Suggested

4 hours ago, 00:17
@StandardMedia - By: Macharia Kamau
Telcos lose control of agents as unregistered SIM cards rocket

Rush for sales sidesteps regulations on customer identification and exposes subscribers to fraud. ...

Category: topnews news business
4 hours ago, 00:17
@StandardMedia - By: Moses Omusolo
Vivo wraps up Engen deal for Sh20 billion

Pact will see firm take over rival’s outlets in eight countries, including Kenya. ...

Category: business news
11 hours ago, 17:19
@DailyNation - By: Lynet Igadwah
Mobile firms given 2 days to switch off illegal subscribers

Mobile operators have until Friday to remove unregistered subscribers and those listed using fraudulent documents from their networks or face fines of up to 0.2 per cent of their annual sales. ...

Category: topnews news business
11 hours ago, 17:08
@BusinessDaily - By: Jenny Lues
It’s time to rethink our expenditure plans

Kenya finds itself at a crossroads. It needs a better future, in terms of health and education, and lives lived. But in our modern world that depends on money, and money is made by business. ...

Category: business news markets economy lifestyle opinion
17 hours ago, 11:37
@DailyNation - By: Constant Munda
Treasury sees growth hitting seven-year high

The imposition VAT on fuel has triggered widespread fears that the economy is bound to deeply suffer. ...

Category: topnews news business
11 hours ago, 17:19
@BusinessDaily - By: Nasibo Kabale
Medics in strike threat over Pumwani saga

Doctors have threatened to go on a countrywide strike if the suspended colleagues from Pumwani hospital are not reinstated. ...

Category: business economy news corporate
Our App